Papers
1
Total Citations
6
H-Index
1
About
Dr. Ruggero Capra is a leading neurologist whose research focuses on multiple sclerosis (MS), particularly the complexities of disease-modifying therapies and their associated risks. His work has significantly advanced the understanding of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection linked to natalizumab treatment. In a highly cited 2017 study, Dr. Capra demonstrated that multidisciplinary rehabilitation can induce neural plasticity and yield functional improvement in MS patients, even when their condition is complicated by PML. This groundbreaking finding challenged previous assumptions about recovery potential in such severe cases. With over 6 citations on this key paper alone, his research has shaped clinical guidelines for managing MS patients on immunosuppressive therapies. Dr. Capra’s contributions extend to exploring the interplay between neuroinflammation and neurorepair, offering hope for more holistic treatment approaches. His work remains essential reading for clinicians and researchers navigating the delicate balance between therapeutic efficacy and safety in MS care.
Research Focus
Key Achievements
Top Papers
- 1